GB2367242B - Antiviral treatment - Google Patents

Antiviral treatment

Info

Publication number
GB2367242B
GB2367242B GB0023199A GB0023199A GB2367242B GB 2367242 B GB2367242 B GB 2367242B GB 0023199 A GB0023199 A GB 0023199A GB 0023199 A GB0023199 A GB 0023199A GB 2367242 B GB2367242 B GB 2367242B
Authority
GB
United Kingdom
Prior art keywords
antiviral treatment
antiviral
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0023199A
Other versions
GB2367242A (en
GB0023199D0 (en
Inventor
Christopher Edward Hartley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henderson Morley Research and Development Ltd
Original Assignee
Henderson Morley Research and Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henderson Morley Research and Development Ltd filed Critical Henderson Morley Research and Development Ltd
Priority to GB0023199A priority Critical patent/GB2367242B/en
Publication of GB0023199D0 publication Critical patent/GB0023199D0/en
Priority to EP01967534A priority patent/EP1322316B1/en
Priority to PCT/GB2001/004206 priority patent/WO2002024207A1/en
Priority to AU2001287907A priority patent/AU2001287907A1/en
Priority to AT01967534T priority patent/ATE435019T1/en
Priority to DE60139134T priority patent/DE60139134D1/en
Priority to US10/380,886 priority patent/US20040034016A1/en
Publication of GB2367242A publication Critical patent/GB2367242A/en
Application granted granted Critical
Publication of GB2367242B publication Critical patent/GB2367242B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB0023199A 2000-09-21 2000-09-21 Antiviral treatment Expired - Fee Related GB2367242B (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GB0023199A GB2367242B (en) 2000-09-21 2000-09-21 Antiviral treatment
EP01967534A EP1322316B1 (en) 2000-09-21 2001-09-21 Diuretic or sulphonylurea for use in antiviral treatment
PCT/GB2001/004206 WO2002024207A1 (en) 2000-09-21 2001-09-21 Diuretic or sulphonylurea for use in antiviral treatment
AU2001287907A AU2001287907A1 (en) 2000-09-21 2001-09-21 Diuretic or sulphonylurea for use in antiviral treatment
AT01967534T ATE435019T1 (en) 2000-09-21 2001-09-21 DIURETIC OR SULFONYL UREA FOR USE IN ANTIVIRAL TREATMENT
DE60139134T DE60139134D1 (en) 2000-09-21 2001-09-21 DIETHETICS OR SULFONYL UREA FOR USE IN ANTIVIRAL TREATMENT
US10/380,886 US20040034016A1 (en) 2000-09-21 2001-09-21 Diuretic or sulphonylurea for use in antiviral treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0023199A GB2367242B (en) 2000-09-21 2000-09-21 Antiviral treatment

Publications (3)

Publication Number Publication Date
GB0023199D0 GB0023199D0 (en) 2000-11-01
GB2367242A GB2367242A (en) 2002-04-03
GB2367242B true GB2367242B (en) 2004-07-28

Family

ID=9899887

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0023199A Expired - Fee Related GB2367242B (en) 2000-09-21 2000-09-21 Antiviral treatment

Country Status (1)

Country Link
GB (1) GB2367242B (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2044101A (en) * 1979-02-22 1980-10-15 Sandoz Ltd Antihypertensive pharmaceutical compositions
EP0068408A1 (en) * 1980-11-10 1983-01-05 Mochida Pharmaceutical Co., Ltd. Antiviral compositions and a method for treating virus diseases
US4757089A (en) * 1985-06-14 1988-07-12 Massachusetts Eye And Ear Infirmary Increasing aqueous humor outflow
US5026690A (en) * 1986-08-02 1991-06-25 Chemische Fabrik Stockhausen Gmbh Antiviral agent
US5650541A (en) * 1993-04-19 1997-07-22 Alcon Laboratories, Inc. Ethacrynic acid-like compounds and use thereof to treat glaucoma
WO2000010574A1 (en) * 1998-08-24 2000-03-02 Hadasit Medical Research Services And Development Ltd. The use of loop diuretics for hiv infection
WO2001049242A2 (en) * 1999-12-30 2001-07-12 Henderson Morley Research And Development Limited Combinations for the treatment of dna viral infections comprising a loop diuretic cardiac glycoside

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2044101A (en) * 1979-02-22 1980-10-15 Sandoz Ltd Antihypertensive pharmaceutical compositions
EP0068408A1 (en) * 1980-11-10 1983-01-05 Mochida Pharmaceutical Co., Ltd. Antiviral compositions and a method for treating virus diseases
US4757089A (en) * 1985-06-14 1988-07-12 Massachusetts Eye And Ear Infirmary Increasing aqueous humor outflow
US5026690A (en) * 1986-08-02 1991-06-25 Chemische Fabrik Stockhausen Gmbh Antiviral agent
US5650541A (en) * 1993-04-19 1997-07-22 Alcon Laboratories, Inc. Ethacrynic acid-like compounds and use thereof to treat glaucoma
WO2000010574A1 (en) * 1998-08-24 2000-03-02 Hadasit Medical Research Services And Development Ltd. The use of loop diuretics for hiv infection
WO2001049242A2 (en) * 1999-12-30 2001-07-12 Henderson Morley Research And Development Limited Combinations for the treatment of dna viral infections comprising a loop diuretic cardiac glycoside

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Virology; Vol 219, pp 291-294 (1996). Voss et al. *

Also Published As

Publication number Publication date
GB2367242A (en) 2002-04-03
GB0023199D0 (en) 2000-11-01

Similar Documents

Publication Publication Date Title
GB0028264D0 (en) Well treatment
GB0028269D0 (en) Well treatment
EP1296698A4 (en) Therapeutic agents - ii
GB0028429D0 (en) Therapy
PL362855A1 (en) Improved treatment
EG25829A (en) Novel treatment
GB2358194B (en) Electrolytic treatment
GB0030845D0 (en) Novel treatment
GB0003284D0 (en) Anti-viral therapy
GB0030541D0 (en) Medical uses
GB0026015D0 (en) Cancer treatment
CA91213S (en) Rollator
IL151871A0 (en) Restenosis treatment
GB0031321D0 (en) Treatment
GB0029125D0 (en) Novel treatment
GB2367242B (en) Antiviral treatment
GB0012497D0 (en) Antiviral therapy
GB0104030D0 (en) Antiviral treatment
GB0104031D0 (en) Antiviral treatment
GB0019728D0 (en) Novel treatment
GB0000683D0 (en) Antiviral treatment
GB0130694D0 (en) Treatment
GB0012760D0 (en) Treatment
GB0017495D0 (en) Treatment
GB0012793D0 (en) Treatment

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20130921